CMA

Nick Kaye copy.jpg bookmark_icon_off

NPA to seek competition watchdog's views on hub and spoke proposals

Concerns that hub and spoke could weaken independents' buying margins and concentrate wholesaler power.

1 Min Article

Disqualified 1280.jpg bookmark_icon_off

CMA disqualifies former Lexon director over illegal information sharing

Watchdog disqualifies Pritesh Sonpal from taking up a director's role in Britain for four years.

1 Min Article

tablet medicine drug summary.jpg bookmark_icon_off

Drug companies fined £260m for hydrocortisone price fixing

Drug companies fined £260m for "excessive and unfair" price hikes to hydrocortisone tablets over a 10 year period.

1 Min Article

drug-tablet-pill-medicine-CMA-collusion-summary.jpg bookmark_icon_off

GSK fined £22m over paroxetine 'pay for delay' deal

The Competition Appeal Tribunal has upheld a previous finding that GSK paid generic drugs companies £50m to delay bringing paroxetine to the market.

1 Min Article

money notes cash finance financial profit summary.jpg bookmark_icon_off

Lexon's appeal against £1.2m fine for collusion dismissed

The Competition Appeal Tribunal has dismissed pharmaceutical company Lexon’s appeal against a £1.2m fine for breaking competition law. 

1 Min Article

Bipolar 620.jpg bookmark_icon_off

Patients can access bipolar drug Priadel for next five years

Bipolar disorder drug Priadel will be made available to patients at a reasonable price for the next five years.

1 Min Article

Essential Pharma Logo.jpg bookmark_icon_off

Priadel manufacturer 'can't withdraw supply' under new terms

Essential agrees to continue to supply lithium drug in UK for at least five years.

1 Min Article

contactless payment pharmacy summary.jpg bookmark_icon_off
GPhC

Watchdog investigating pharmacies over handgel prices

The CMA has launched investigations into four retailers, including pharmacies, suspected of charging “excessive and unfair prices”.

1 Min Article

medicine-tablet-summary.jpg bookmark_icon_off

Pharma director disqualified for breaking competition law

A director of a pharmaceutical manufacturer has been barred from holding a directorship at any UK company after admitting to his role in two separate anticompetitive agreements.

1 Min Article

money notes cash finance financial profit.jpg bookmark_icon_off

Lexon appeals against £1.2m nortriptyline fine

CMA says it will defend an appeal brought by Lexon against a £1.2m fine for allegedly sharing commercially sensitive information.

1 Min Article

Loading